seqWell

seqWell was created to revolutionize NGS library prep to unlock the full potential of todays DNA sequencing instruments. Our plexWellTM platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes. In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking. We invite you to learn more at https://seqwell.com

Gene sequencing,laboratory services,and ngs library prep

Seqwell operates in the Biotechnology industry.

Seqwell's revenue is 11m - 100m

Seqwell has 11 - 50 employees.